Valuation: Procyon Corporation

Market Cap 15.47L 13.74L 12.83L 11.69L 22.05L 15Cr 22.25L 1.55Cr 60.15L 7.6Cr 58.07L 56.81L 24Cr P/E 2023
-25x
P/E 2024 -5.75x
Enterprise Value 10.65L 9L 9L 8L 15.18L 10Cr 15.32L 1.07Cr 41.4L 5.23Cr 39.97L 39.1L 17Cr EV / Sales 2023
0.34x
EV / Sales 2024 0.28x
Free-Float
35.53%
Yield 2023 *
-
Yield 2024 -
1 day+48.94%
1 week+3.70%
Current month+3.70%
1 month+12.00%
3 months+39.30%
Current year+131.40%
1 week 0.27
Extreme 0.27
0.28
1 month 0.26
Extreme 0.26
0.28
Current year 0.12
Extreme 0.12
0.28
1 year 0.12
Extreme 0.12
0.28
3 years 0
Extreme 1.0E-6
0.34
5 years 0
Extreme 1.0E-6
0.64
10 years 0
Extreme 1.0E-6
1
Manager TitleAgeSince
Chief Executive Officer 49 09/01/2018
Chief Executive Officer 56 22/09/2005
Director TitleAgeSince
Director/Board Member 49 01/01/2006
Director/Board Member 56 01/12/2006
Chairman 79 01/09/2005
Date Insider Type Main position Quantity % Market Cap. Importance
31/07/24 Other

Director

12,848 0.1585%
31/07/24 Other

Director

7,200 0.0888%
31/07/24 Other

Director

5,600 0.0691%
Change 5-day change 1-year change 3-year change Capi.($)
+48.94%+3.70%+127.64%-.--% 22.13L
-0.61%-3.43%+39.40%+112.31% 1,01900Cr
-1.02%-5.60%+37.67%+65.02% 62TCr
+1.11%-0.58%+11.10%+77.28% 46TCr
+0.34%-3.01%+61.21%+40.71% 36TCr
-0.95%-4.05%+21.60%+39.37% 33TCr
-1.46%-2.89%+11.84%+24.60% 27TCr
-1.35%-5.43%-4.69%+8.40% 24TCr
-1.04%-2.79%+35.52%+51.34% 22TCr
-1.87%-4.10%+30.92%+95.33% 18TCr
Average +4.68%-3.05%+37.22%+51.44% 36.97TCr
Weighted average by Cap. +0.42%-3.33%+30.52%+68.96%

Financials

2023 2024
Net sales 46.87L 41.64L 38.87L 35.42L 66.81L 45Cr 67.43L 4.7Cr 1.82Cr 23Cr 1.76Cr 1.72Cr 74Cr 49.84L 44.29L 41.33L 37.67L 71.05L 48Cr 71.72L 5Cr 1.94Cr 24Cr 1.87Cr 1.83Cr 79Cr
Net income -50.24T -44.64T -41.67T -37.98T -71.63T -48.3L -72.29T -5L -2L -24.69L -2L -2L -79.25L -3L -3L -3L -3L -5L -3.28Cr -5L -34.24L -13.27L -1.68Cr -12.81L -12.53L -5.38Cr
Net Debt -4L -4L -4L -3L -6L -4.11Cr -6L -42.9L -16.62L -2.1Cr -16.05L -15.7L -6.74Cr -5L -4L -4L -4L -7L -4.63Cr -7L -48.38L -18.75L -2.37Cr -18.1L -17.71L -7.6Cr
Logo Procyon Corporation
Procyon Corporation operates through its subsidiary AMERX Health Care Corporation (AMERX). AMERX develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. It provides skin and wound care products through its proprietary brands, AMERIGEL Advanced Skin and Wound Care, HELIX3 Bioactive Collagen, and EXTREMIT-EASE compresson Garment. Its AMERIGEL products are made with Oakin, that promote healing in wounds and problematic skin conditions while fighting infection, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder (HELIX3 CP) and Collagen Matrix (HELIX3 CM). Its kits and dressings products include AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Thin Hydrocolloid Dressings, and AMERX Wound Care Kits.
Employees
20
Date Price Change Volume
28/26/28 $0.2700 -.--% 5,501
  1. Stock Market
  2. Stocks
  3. PCYN Stock